key: cord-0814637-dzcfa7c3 authors: Kim, Min Jung; Shim, Doo Hee; Cha, Hye‐Ran; Moon, Kuk‐Young; Yang, Chang Mo; Hwang, Su Jin; Kim, Kyung Won; Park, Jeon Han; Lee, Chun Geun; Elias, Jack A.; Sohn, Myung Hyun; Lee, Jae Myun title: Chitinase 3‐like 1 protein plays a critical role in respiratory syncytial virus‐induced airway inflammation date: 2018-12-04 journal: Allergy DOI: 10.1111/all.13661 sha: c55ffd0a07962fa75503b8b94d92f69b106be942 doc_id: 814637 cord_uid: dzcfa7c3 BACKGROUND: Chitinase 3‐like 1 protein (CHI3L1) (YKL‐40 in humans and breast regression protein [BRP]‐39 in mice) is required for optimal allergen sensitization and Th2 inflammation in various chronic inflammatory diseases including asthma. However, the role of CHI3L1 in airway inflammation induced by respiratory viruses has not been investigated. The aim of this study was to investigate the relationship between CHI3L1 and airway inflammation caused by respiratory syncytial virus (RSV) infection. METHODS: We measured YKL‐40 levels in human nasopharyngeal aspirate (NPA) from hospitalized children presenting with acute respiratory symptoms. Wild‐type (WT) and BRP‐39 knockout (KO) C57BL/6 mice were inoculated with live RSV (A2 strain). Bronchoalveolar lavage fluid and lung tissue samples were obtained on day 7 after inoculation to assess lung inflammation, airway reactivity, and expression of cytokines and BRP‐39. RESULTS: In human subjects, YKL‐40 and IL‐13 levels in NPA were higher in children with RSV infection than in control subjects. Expression of BRP‐39 and Th2 cytokines, IL‐13 in particular, was increased following RSV infection in mice. Airway inflammation caused by RSV infection was reduced in BRP‐39 KO mice as compared to WT mice. Th2 cytokine levels were not increased in the lungs of RSV‐infected BRP‐39 KO mice. BRP‐39 regulated M2 macrophage activation in RSV‐infected mice. Additionally, treatment with anti‐CHI3L1 antibody attenuated airway inflammation and Th2 cytokine production in RSV‐infected WT mice. CONCLUSION: These findings suggest that CHI3L1 could contribute to airway inflammation induced by RSV infection. CHI3L1 could be a potential therapeutic candidate for attenuating Th2‐associated immunopathology during RSV infection. Respiratory syncytial virus (RSV) is the virus most commonly associated with bronchiolitis affecting infants and young children. [1] [2] [3] can induce lower respiratory tract illness (LRTI), which encompasses bronchiolitis and viral pneumonia can lead to death in severe cases. 4 All children have been infected with RSV by the age of 2 years, and nearly half of these cases will experience recurrent infections. 5 A large proportion of young patients with RSV bronchiolitis have recurrent episodes of lower airway obstruction, which may continue for years after the acute infection has resolved. 2 Several prospective birth cohort studies have reported that early-life RSV-associated LRTI plays an important causative role in the pathogenesis of recurrent wheezing and asthma. [5] [6] [7] However, current therapeutic options are limited to supportive treatment focusing on fluid and respiratory maintenance, and there is a need for more widely available and cost-effective preventative measures. 8 In addition, the mechanism by which RSV evades host defenses is not fully understood. 2 Clarifying RSV pathogenesis in humans and developing prophylactic or therapeutic strategies for RSV infection in the respiratory tract is required. Recently, chitinase 3-like 1 protein (CHI3L1) (YKL-40 in humans and breast regression protein [BRP]-39 in mice) has been implicated in the development of asthma. Circulating levels of YKL-40 were increased in patients with asthma, which was correlated with disease severity. 9 CHI3L1 variants affected serum YKL-40 levels and influenced asthma status and lung function. 10 BRP-39 was identified as an important regulator of allergic responses and tissue remodeling in mice. 11 CHI3L1 has also been linked to other types of chronic lung inflammation 12, 13 and acute lung injury. 14 However, the role of CHI3L1 in viral respiratory infection has not been previously investigated. In this study, we hypothesized that CHI3L1 is involved in airway inflammation induced by RSV infection. To investigate this possibility, we measured YKL-40 in human nasopharyngeal aspirates (NPAs) from hospitalized children presenting with acute respiratory symptoms, and compared the immune responses induced by RSV in wildtype (WT) and BRP-39 knockout (KO) mice. We found that RSV infection induced IL-13-dominant immune responses in a murine model and that CHI3L1/BRP-39 may enhance airway hyperresponsiveness (AHR), inflammatory cell recruitment, and mucus production in RSV-infected mice. Moreover, treatment with anti-CHI3L1 antibody attenuated RSV-induced airway inflammation and Th2 cytokine production in RSV-infected WT mice, suggesting that CHI3L1 is a therapeutic candidate for the treatment of RSV-associated LRTI. From December in 2015 to February in 2018, nasopharyngeal aspirates were collected from children hospitalized at Severance Respiratory syncytial virus infection induces increased expression of BRP-39 by macrophages and epithelial cells that is related to Th2 inflammation. A lack of BRP-39 attenuates RSV-induced airway inflammation and IL-13 responses. BRP-39 is an important regulator of RSV infection and suggested as a potential therapeutic target for RSV-related respiratory illness. Children's Hospital due to acute respiratory symptoms such as coughing, wheezing, or tachypnea. For NPA collection, a sterile suction catheter was inserted into the oropharynx through the nostril and gentle suction was applied using an electric suction pump. 15 After washing the catheter with normal saline, samples were placed into viral transport medium and kept at −70°C until further pro- The RSV A2 strain was propagated in HEp-2 cells (American Type Culture Collection, Manassas, VA, USA) and harvested on days 4 postinfection (dpi) when the cytopathic effect in infected cells was maximal. The final titer was also established in HEp-2 cells and determined with the standard plaque assay. 17 Lung resistance was measured at 7 dpi as previously described. 18 Paraffin-embedded and sectioned lung specimens were stained with hematoxylin and eosin (H&E) or periodic acid-Schiff (PAS) to assess inflammation and mucus production, respectively. BRP-39 expression was detected by IHC using a human cartilage glycoprotein- Muc5AC protein was measured by ELISA, as previously described by Lee et al. 19 TaqMan primer-probe sets for IL-4, IL-5, IL-13, CHI3L1, and GAPDH were purchased from Applied Biosystems (Foster City, CA, USA). Relative mRNA levels of IL-4, IL-5, IL-13, and CHI3L1 were determined with the comparative ΔΔC T method. For RSV quantification, known concentrations of RSV A2 were used to generate a standard curve. Standards and negative controls were included in each PCR assay. Customized TaqMan primer-probe sets for the RSV N gene, a wellconserved region of RSV A2, were used. 20 Gene expression was quantified using a StepOne Real-Time PCR system (Applied Biosystems). After whole lung from mouse prepared followed as previously described, 18 To assess alternative macrophage activation, alveolar macrophages in BALF and lung cells were examined for surface expression of CD206. Arginase activity in BALF and lung lysates was measured using the QuantiChrom Arginase Assay kit (BioAssay Systems, Hayward, CA, USA) according to the manufacturer's instructions. 21 WT RSV-infected mice were administered a single 50-μg dose of anti-CHI3L1 antibody (AF2649) (R&D Systems) 22 or vehicle via the intraperitoneal route 24 hours after RSV infection. Mice were euthanized on 7 dpi, and inflammation and immune responses induced by RSV infection were analyzed. Changes in BRP-39 expression were also noted. Lungs harvested from each group were stained with H&E or PAS to evaluate inflammation and mucus production, respectively. Baseline characteristics of patients were compared with the Mann-Whitney U test or Fisher's exact test as appropriate. Correlations between YKL-40 and IL-13 levels in NPA were determined with Spearman's rank correlation test. Data were analyzed with SPSS v.20.0 software (SPSS Inc., Chicago, IL, USA). And experimental data were expressed as mean ± SD. Groups were compared with the unpaired Student's t test, 1-way ANOVA with the bonferroni correction, as appropriate using Prism v.6.04 software (GraphPad Inc., La Jolla, CA, USA). P < 0.05 was considered statistically significant. To investigate the relationship between CHI3L1 and RSV infection, YKL-40 levels in NPA samples from hospitalized children were measured ( Figure 1A) . The clinical characteristics of the subjects are summarized in Table S1 . Between the 43 patients with RSV infection and 12 patients without any confirmed pathogens, there were no significant differences in age, gender, duration of admission, past history, and laboratory findings. Children with confirmed RSV infection showed higher scores for acute respiratory symptoms at the time of admission than the control group (P < 0.001). Children with RSV infection had higher YKL-40 ( Figure 1B We compared BRP-39 expression between control and RSV-infected mice on 7 dpi. As in children with RSV infection, BRP-39 levels in the lungs and BALF were increased in RSV-infected as compared to control mice (Figure 2A A histological analysis revealed that tissue inflammation ( Figure 3D) and mucus production ( Figure 3E ,F) were also decreased in RSVinfected BRP-39 null mice. There was no difference in viral load after RSV infection between WT and BRP-39 KO mice ( Figure 3G ). These data indicate that loss of BRP-39 could attenuate airway inflammation induced by RSV infection, without significant changes in viral load. while having no effect on the production of other inflammatory cytokines. We next investigated the mechanisms by which BRP-39 drives Th2 inflammation and AHR during RSV infection in mice. Since alternatively activated (M2) macrophages are known to affect Th2 inflammation during RSV infection and are associated with BRP-39 and allergic inflammation, we evaluated macrophage activation and found that the number of M2 macrophages in BALF and lung cells was increased in infected mice ( Figure 5A,C) . Moreover, M2 macrophage arginase 1 activity in BALF ( Figure 5B ) and lung lysates ( Figure 5D ) was increased in infected WT and BRP-39 KO mice, although it was >50% lower in the latter. These results indicate that BRP-39 regulates the accumulation and activation of M2 macrophages and induces IL-13-dominant Th2 inflammation during RSV infection. Consistent with data of decreased RSV-induced airway inflammation in BRP-39 null mice, we evaluated the therapeutic effects of anti-CHI3L1 antibody in RSV infection. And we found that a single 50-μg dose of antibody administered to WT mice by intraperitoneal injection 24 hours after RSV infection decreased the inflammatory response ( Figure 6A -D) as well as BRP-39 expression ( Figure 6E ,F) relative to non-treated WT RSV mice. A histological examination revealed that inflammation ( Figure 6G ) and mucus production ( Figure 6H) were also decreased by the antibody treatment, which had no effect on viral load in the lungs ( Figure 6I ). Th2 cytokine levels were also decreased in mice treated with anti-CHI3L1 antibody as compared to the control group, with IL-13 showing the greatest reduction ( Figure 6J The burden of respiratory syncytial virus infection in young children Viral bronchiolitis in children Viral bronchiolitis Respiratory syncytial virus interaction with human airway epithelium Respiratory syncytial virus and asthma: speed-dating or long-term relationship? The role of early life viral bronchiolitis in the inception of asthma Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life In hot pursuit of the first vaccine against respiratory Syncytial virus A Chitinase-like protein in the lung and circulation of patients with severe asthma Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxiainduced acute lung injury Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses Comparative study of nasopharyngeal aspirate and nasal swab specimens for diagnosis of acute viral respiratory infection Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant Pandemic influenza virus, pH1N1, induces asthmatic symptoms via activation of innate lymphoid cells Suppressive effects of coixol, glyceryl trilinoleate and natural products derived from Coix Lachryma-Jobi var. ma-yuen on gene expression, production and secretion of airway MUC5AC mucin Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis The role of CHI3L1 (Chitinase-3-Like-1) in the pathogenesis of infections in burns in a mouse model Role of breast regression protein-39/YKL-40 in asthma and allergic responses Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor alpha2 Protective and dysregulated T cell immunity in RSV infection The CD4 T cell response to respiratory syncytial virus infection Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review Mechanisms of respiratory syncytial virus modulation of airway immune responses Immune and inflammatory response in bronchiolitis due to respiratory Syncytial Virus and Rhinovirus infections in infants Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent Macrophage polarization in inflammatory diseases IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin Littel-van den Hurk S. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development Respiratory syncytial virus-a comprehensive review Alternatively activated macrophages and airway disease YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-kappaB pathways, causing bronchial smooth muscle proliferation and migration Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation Role of chitinase 3-like-1 in interleukin-18-induced pulmonary type 1, type 2, and type 17 inflammation; alveolar destruction; and airway fibrosis in the murine lung Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells The authors thank Dong-Su Jang for assistance with the illustration. The authors declare that they have no conflicts of interest.